DETTE Changement Date
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amarin USD 0 0 2025-03
Amgen USD 57.3B 19M 2026-06
Baxter International USD 9.67B 20M 2026-06
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 1.27B 18.17M 2026-06
DBV Technologies USD 7.5M 1.4M 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
MannKind USD 330.85M 112K 2026-06
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 62.67B 523M 2026-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12